AQR Arbitrage LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$16,493
-62.0%
294,5250.0%0.00%
-50.0%
Q2 2023$43,413
+53.8%
294,525
-0.8%
0.00%
+100.0%
Q1 2023$28,219
-9.5%
297,039
-4.8%
0.00%0.0%
Q4 2022$31,167
+24.7%
311,9770.0%0.00%0.0%
Q3 2022$25,000
-43.2%
311,9770.0%0.00%0.0%
Q2 2022$44,000
-36.2%
311,9770.0%0.00%
-50.0%
Q1 2022$69,000311,9770.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$2,007,0000.05%
Q Global Advisors, LLC 195,489$18,0000.01%
RAMIUS ADVISORS LLC 196,073$16,0000.01%
EHP Funds Inc. 137,276$20,0000.00%
Telemetry Investments, L.L.C. 33,303$3,0000.00%
MARSHALL WACE, LLP 190,150$1,930,0000.00%
PERISCOPE CAPITAL INC. 735,572$97,0000.00%
Spartan Fund Management Inc. 75,000$11,0000.00%
Union Square Park Capital Management, LLC 25,000$2,0000.00%
KIM, LLC 250,000$36,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders